This site needs JavaScript to work properly. Please enable it to take advantage of the complete set of features!

Skip to main page content

Add to Collections

Your saved search

Name of saved search:

Search terms:

Test search terms

Would you like email updates of new search results?

Yes
No

Email: (change)

Frequency:

Which day?

Which day?

Report format:

Send at most:

Send even when there aren't any new results

Optional text in email:

Your RSS Feed

Comment

. 2023 Dec;10(12):e942-e943.

doi: 10.1016/S2352-3026(23)00311-3. Epub 2023 Oct 31.

Is dose-adjusted EPOCH-R the new standard for high-risk Burkitt lymphoma?

Kenneth J C Lim¹, Robin Filshie²

Affiliations

Affiliations

¹ St Vincent's Hospital Melbourne, Melbourne, VIC, 3065 Australia. Electronic address: kenneth.lim@svha.org.au.
² St Vincent's Hospital Melbourne, Melbourne, VIC, 3065 Australia.

PMID: 37922924
DOI: 10.1016/S2352-3026(23)00311-3

Comment

Is dose-adjusted EPOCH-R the new standard for high-risk Burkitt lymphoma?

Kenneth J C Lim et al. Lancet Haematol. 2023 Dec.

. 2023 Dec;10(12):e942-e943.

doi: 10.1016/S2352-3026(23)00311-3. Epub 2023 Oct 31.

Authors

Kenneth J C Lim¹, Robin Filshie²

Affiliations

¹ St Vincent's Hospital Melbourne, Melbourne, VIC, 3065 Australia. Electronic address: kenneth.lim@svha.org.au.
² St Vincent's Hospital Melbourne, Melbourne, VIC, 3065 Australia.

PMID: 37922924
DOI: 10.1016/S2352-3026(23)00311-3

No abstract available

PubMed Disclaimer

Conflict of interest statement

We declare no competing interests.

Comment on

R-CODOX-M/R-IVAC versus DA-EPOCH-R in patients with newly diagnosed Burkitt lymphoma (HOVON/SAKK): final results of a multicentre, phase 3, open-label, randomised trial.
Chamuleau MED, Stenner F, Chitu DA, Novak U, Minnema MC, Geerts P, Stevens WBC, Zenz T, van Imhoff GW, Wu KL, Demandt AMP, Kersten MJ, Terpstra WE, Tick LW, Deeren D, Van Den Neste E, Gregor M, Veelken H, Böhmer LH, Caspar CB, Mutsaers P, Refos JM, Sewsaran R, Fu L, Seefat RL, Uyl-de Groot CA, Dirnhofer S, Van Den Brand M, de Jong D, Nijland M, Lugtenburg P. Chamuleau MED, et al. Lancet Haematol. 2023 Dec;10(12):e966-e975. doi: 10.1016/S2352-3026(23)00279-X. Epub 2023 Oct 31. Lancet Haematol. 2023. PMID: 37922925 Clinical Trial.

Publication types

Actions

MeSH terms

Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions
Actions

Substances

Actions
Actions
Actions
Actions
Actions

Supplementary concepts

Actions

LinkOut - more resources

Full Text Sources
- ClinicalKey
- Elsevier Science